Department of Infectious Diseases and Clinic Microbiology, Dicle University Medical School, 21280 Diyarbakir, Turkey.
Int J Infect Dis. 2009 Nov;13(6):e424-30. doi: 10.1016/j.ijid.2009.01.021. Epub 2009 May 2.
The objectives of this study were to identify the causative microorganisms and factors associated with survival in patients with Fournier's gangrene and to determine the accuracy of the Fournier's gangrene severity index.
We retrospectively evaluated 27 patients with Fournier's gangrene who were treated and followed up at our hospital between January 2005 and December 2006. Biochemical, hematologic, and bacteriologic study results at admission and at the final evaluation, etiologic and predisposing factors at admission, physical examination findings, the timing and extent of surgical debridement, and antibiotic therapy used were all recorded.
The admission laboratory parameters that were significantly correlated with outcome included urea, creatinine, sodium, and potassium; at the final evaluation, in addition to these parameters, hematocrit, albumin, and bicarbonate levels were also significantly associated with outcome. The mean Fournier's gangrene severity index score (FGSIS) at admission for survivors was 5.04+/-2.49 compared with 13.6+/-4.61 for non-survivors. There was a strong correlation between the FGSIS and mortality (p<0.0001). Escherichia coli and Pseudomonas aeruginosa were the most commonly isolated microorganisms.
Patient metabolic status and predisposing factors are important in the prognosis of Fournier's gangrene. Hence, we believe that the FGSIS should be used clinically to evaluate therapeutic options and assess results.
本研究旨在确定导致坏疽性脓皮病的微生物和相关因素,并确定坏疽性脓皮病严重指数的准确性。
我们回顾性评估了 2005 年 1 月至 2006 年 12 月期间在我院接受治疗和随访的 27 例坏疽性脓皮病患者。记录了入院时和最终评估时的生化、血液和细菌学研究结果、入院时的病因和易患因素、体检结果、手术清创的时机和范围以及使用的抗生素治疗。
与预后显著相关的入院实验室参数包括尿素、肌酐、钠和钾;在最终评估中,除了这些参数外,红细胞压积、白蛋白和碳酸氢盐水平也与预后显著相关。幸存者的平均坏疽性脓皮病严重指数评分(FGSIS)为 5.04+/-2.49,而非幸存者为 13.6+/-4.61。FGSIS 与死亡率之间存在很强的相关性(p<0.0001)。大肠杆菌和铜绿假单胞菌是最常见的分离微生物。
患者代谢状况和易患因素是坏疽性脓皮病预后的重要因素。因此,我们认为 FGSIS 应在临床上用于评估治疗方案和评估结果。